We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?
Discover the latest in pathology and laboratory medicine with this roundup of short news stories
A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
Targeting a pathway that promotes cancer immune evasion could prolong immunotherapy and reduce its side effects for liver cancer patients
The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map
The WHO’s Classification of Tumors series is entering its fifth edition – and many accessibility improvements make the latest Blue Books the best yet
Simultaneous multiplex immunohistochemistry can provide efficient testing of multiple targets when diagnosing and selecting treatment for cancer
A new imaging technique provides detailed views of tumor cells, allowing researchers to visualize the transition from precancerous to cancerous
The microbial diversity and species distribution of the cervix may help diagnosticians determine the patients at increased risk of cervical cancer.
A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.
Send me the latest from The Pathologist.
Comprehensive genomic profiling assays provide extensive coverage of variants and immunotherapy biomarkers and increasingly enable physicians to provide cancer patients with more informed treatments.
by Thermo Fisher Scientific
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.